Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
复制标题
DLG5 缺失通过抑制 Hippo 信号通路促进乳腺癌恶性
DOI:
10.1038/srep42125
复制
发表时间:
2017-02-07
影响因子:
4.6
通讯作者:
Liu P
中科院分区:
文献类型:
--
作者:
Liu J;Li J;Li P;Wang Y;Liang Z;Jiang Y;Li J;Feng C;Wang R;Chen H;Zhou C;Zhang J;Yang J;Liu P
Discs Large Homolog 5 (DLG5) plays an important role in the maintenance of epithelial cell polarity. Recent research showed that DLG5 is decreased in Yes-associated protein (YAP)-overexpressing cells. However, the exact relationship between DLG5 and YAP is not clear. In this study, we showed that loss of DLG5 promoted breast cancer cell proliferation by inhibiting the Hippo signaling pathway and increasing nuclear YAP expression. Furthermore, depletion of DLG5 induced epithelial-mesenchymal transition (EMT) and disrupted epithelial cell polarity, which was associated with altered expression of Scribble, ZO1, E-cadherin and N-cadherin and their mislocalization. Interestingly, we first reported that loss of DLG5 inhibited the interaction of Mst1 and Lats1 with Scribble, which was crucial for YAP activation and the transcription of TEA domain (TEAD) family members. In summary, loss of DLG5 expression promoted breast cancer malignancy by inactivating the Hippo signaling pathway and increasing nuclear YAP.